Correlation Between Connect Biopharma and Petros Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Connect Biopharma and Petros Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Connect Biopharma and Petros Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Connect Biopharma Holdings and Petros Pharmaceuticals, you can compare the effects of market volatilities on Connect Biopharma and Petros Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Connect Biopharma with a short position of Petros Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Connect Biopharma and Petros Pharmaceuticals.

Diversification Opportunities for Connect Biopharma and Petros Pharmaceuticals

0.88

Correlation Coefficient

Connect Biopharma  Petros Pharmaceuticals

Very poor diversification

The 3 months correlation between Connect and Petros is 0.88. Overlapping area represents the amount of risk that can be diversified away by holding Connect Biopharma Holdings and Petros Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Petros Pharmaceuticals and Connect Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Connect Biopharma Holdings are associated (or correlated) with Petros Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Petros Pharmaceuticals has no effect on the direction of Connect Biopharma i.e., Connect Biopharma and Petros Pharmaceuticals go up and down completely randomly.

Pair Corralation between Connect Biopharma and Petros Pharmaceuticals

Given the investment horizon of 90 days Connect Biopharma Holdings is expected to under-perform the Petros Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Connect Biopharma Holdings is 5.06 times less risky than Petros Pharmaceuticals. The stock trades about -0.22 of its potential returns per unit of risk. The Petros Pharmaceuticals is currently generating about -0.02 of returns per unit of risk over similar time horizon. If you would invest  37.00  in Petros Pharmaceuticals on December 29, 2024 and sell it today you would lose (26.00) from holding Petros Pharmaceuticals or give up 70.27% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

Connect Biopharma Holdings  vs.  Petros Pharmaceuticals

Connect Biopharma

Risk-Adjusted Performance

Very Weak

Over the last 90 days Connect Biopharma Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Petros Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Petros Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in April 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Pair Trading with Connect Biopharma and Petros Pharmaceuticals

The main advantage of trading using opposite Connect Biopharma and Petros Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Connect Biopharma position performs unexpectedly, Petros Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Petros Pharmaceuticals will offset losses from the drop in Petros Pharmaceuticals' long position.

The idea behind Connect Biopharma Holdings and Petros Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .